A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects
Clinical trial NCT05332834 · COMPLETED
Trial details
- NCT number
- NCT05332834
- Sponsor
- SinoMab BioScience Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-14
- Primary completion
- 2023-09-26
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.